R65L (p.Arg65Leu) variant of KRT1 (Keratin, type II cytoskeletal 1)

R65L (p.Arg65Leu) in KRT1 (Keratin, type II cytoskeletal 1) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.49 / 1. The record also includes population frequency data and structural context.

R65L (p.Arg65Leu) variant details